Chembio Diagnostics (CEMI) Short Interest Ratio & Short Volume

Short interest is the volume of Chembio Diagnostics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 292,100 shares of CEMI short. Learn More on Chembio Diagnostics' current short interest.

Chembio Diagnostics saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 292,100 shares, a drop of 19.2% from the previous total of 361,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Chembio Diagnostics: PyroGenesis Canada Inc. (0.11%), Aadi Bioscience, Inc. (6.58%), Actinium Pharmaceuticals, Inc. (4.88%), Eagle Pharmaceuticals, Inc. (0.46%), Marinus Pharmaceuticals, Inc. (3.95%), Allakos Inc. (0.37%), Cara Therapeutics, Inc. (1.74%), NanoViricides, Inc. (0.59%), 23andMe Holding Co. (11.90%), GlycoMimetics, Inc. (2.90%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.69 billion), Occidental Petroleum Corporation ($3.22 billion), Coinbase Global, Inc. ($2.54 billion), T. Rowe Price Group, Inc. ($2.33 billion), Paramount Global ($2.10 billion), Verisk Analytics, Inc. ($2.03 billion), Etsy, Inc. ($1.67 billion), Old Dominion Freight Line, Inc. ($1.62 billion), CarMax, Inc. ($1.60 billion), and Extra Space Storage Inc ($1.60 billion). View all of the most shorted stocks.

Short selling CEMI is an investing strategy that aims to generate trading profit from Chembio Diagnostics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Chembio Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CEMI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CEMI, twice per month. The most recent reporting period available is April, 15 2023.